CLINICAL_TRIALS
withdrawal
· 2017-03-24
Clinical Trial Update: Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation (rTMS) [Phase 2]
Summary
A Phase 2 trial investigating repetitive transcranial magnetic stimulation for depersonalization disorder was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Depersonalization Disorder | Phase 2 | Status: WITHDRAWN